Repligen
RGEN
#2302
Rank
NZ$14.66 B
Marketcap
NZ$260.06
Share price
1.23%
Change (1 day)
26.79%
Change (1 year)
Categories

Earnings for Repligen (RGEN)

Earnings in 2025 (TTM): NZ$0.14 Billion

According to Repligen 's latest financial reports the company's current earnings are NZ$0.73 Billion. , an increase over its 2024 earnings that were of -NZ$11.16 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Repligen from 1985 to 2025

Annual earnings

Year Earnings Change
2025 NZ$0.14 B-1430.84%
2024 -NZ$11.16 Million-113.01%
2023 NZ$85.7 M-78.01%
2022 NZ$0.38 B33.37%
2021 NZ$0.29 B131.52%
2020 NZ$0.12 B101.31%
2019 NZ$62.69 M25.93%
2018 NZ$49.79 M105.61%
2017 NZ$24.21 M-11.46%
2016 NZ$27.35 M14.91%
2015 NZ$23.8 M20.26%
2014 NZ$19.79 M-51.49%
2013 NZ$40.79 M90.98%
2012 NZ$21.36 M
2010 NZ$0.3 M-103.81%
2009 -NZ$8.12 Million-223.84%
2008 NZ$6.55 M
2006 -NZ$4.41 Million229.64%
2005 -NZ$1.34 Million-89.16%
2004 -NZ$12.33 Million-16.86%
2003 -NZ$14.83 Million88.72%
2002 -NZ$7.86 Million-27.88%
2001 -NZ$10.89 Million-1.74%
2000 -NZ$11.09 Million85.93%
1999 -NZ$5.96 Million159.16%
1998 -NZ$2.3 Million85.71%
1997 -NZ$1.24 Million-70.83%
1996 -NZ$4.25 Million-72.41%
1995 -NZ$15.4 Million-60.63%
1994 -NZ$39.1 Million45.39%
1993 -NZ$26.89 Million39.45%
1992 -NZ$19.29 Million-32.3%
1991 -NZ$28.49 Million6.62%
1990 -NZ$26.72 Million1577.78%
1989 -NZ$1.6 Million-57.14%
1988 -NZ$3.72 Million-362.5%
1987 NZ$1.41 M-130.77%
1986 -NZ$4.6 Million136.36%
1985 -NZ$1.95 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$18.73 B 12,523.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
NZ$13.12 B 8,746.67%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
NZ$19.42 B 12,988.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$16.97 B 11,339.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-NZ$0.2 Billion-229.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
NZ$0.82 B 453.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$1.41 B 852.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
NZ$0.21 B 47.18%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.68 B 359.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-NZ$0.18 Billion-218.60%๐Ÿ‡บ๐Ÿ‡ธ USA